Publications

Publications

Filter Results: (479) Arrow Down

Show Results For

← Page 14 of 479 Results →
  • 20 Oct 2011
  • Research & Ideas

Getting the Marketing Mix Right

models—logit, nested logit, and probit, for example—are flawed because they make it appear as if all marketing activities produce the same results, the researchers contend. In reality, differences between various marketing instruments are... View Details
Keywords: by Dina Gerdeman
  • November 2002
  • Compilation

Four Principles of Biomedical Ethics: Definitions and Examples

By: Sandra J. Sucher
Introduces four principles of biomedical ethics, excerpted from Principles of Biomedical Ethics, Tom L. Beauchamp and James F. Childress (Oxford University Press, 2001). The principles provide a conceptual framework for the analysis and resolution of moral problems... View Details
Keywords: Framework; Moral Sensibility; Health Care and Treatment; Distribution; Problems and Challenges; Research; Emotions; Management Analysis, Tools, and Techniques; Pharmaceutical Industry; Pharmaceutical Industry
Related
  • 01 Feb 1999
  • News

Too Much of a Good Thing?

years, sectors as diverse as automobiles, semiconductors, steel, textiles, consumer electronics, tires, and pharmaceuticals have been afflicted by overcapacity and some or all of its unpleasant side effects: loss of jobs, plant closings,... View Details
Keywords: Garry Emmons
  • 05 Sep 2007
  • First Look

First Look: September 5, 2007

critical action phase. We draw on the research on behavioral forecasting, ethical fading, and cognitive distortions to gain insight into the forces driving these faulty perceptions and, noting how these misperceptions can lead to... View Details
Keywords: Martha Lagace
  • 01 Jun 2023
  • News

From Big Pharma to Startup

pharmaceutical giant one day—not creating a company from scratch. But Goble was determined to explore the wide variety of opportunities available to him in his time at HBS, so when he read about a nonprofit life sciences entrepreneurship... View Details
Keywords: April White
  • September 2012 (Revised November 2014)
  • Case

Cialis Lifecycle Management: Lilly's BPH Dilemma

By: Elie Ofek and Natalie Kindred
How should Eli Lilly further develop and market a new indication of its highly successful erectile-dysfunction (ED) drug, Cialis, without confusing Cialis's hard-won brand equity with physicians and patients? With the final stages of clinical trials for the new... View Details
Keywords: Product Positioning; Attitudes; Brands and Branding; Pharmaceutical Industry; United States
Related
  • January–February 2023
  • Article

Data-Driven COVID-19 Vaccine Development for Janssen

By: Dimitris Bertsimas, Michael Lingzhi Li, Xinggang Liu, Jennings Xu and Najat Khan
The COVID-19 pandemic has spurred extensive vaccine research worldwide. One crucial part of vaccine development is the phase III clinical trial that assesses the vaccine for safety and efficacy in the prevention of COVID-19. In this work, we enumerate the first... View Details
Keywords: COVID-19; Health Testing and Trials; Forecasting and Prediction; AI and Machine Learning; Research; Pharmaceutical Industry
Related
  • 28 Apr 2009
  • First Look

First Look: April 28, 2009

behaviors led to undesirable consequences, even if they saw those behaviors as acceptable before they knew the consequences. Furthermore, our results demonstrate that a rational, analytic mindset can override the effects of one's intuitions in ethical judgments.... View Details
Keywords: Martha Lagace
  • 30 Oct 2007
  • First Look

First Look: October 30, 2007

multiple research projects and field observations to analyze problems facing the United States in recent years and to create an agenda for renewing American strengths through returning to core American principles—but in new ways suitable... View Details
Keywords: Sean Silverthorne
  • 05 Aug 2008
  • First Look

First Look: August 5, 2008

to exit direct stockholding if their stock portfolios have performed well; but these relationships are much weaker for mutual funds, a pattern which is consistent with previous research on the disposition effect among direct stockholders... View Details
Keywords: Martha Lagace
  • 22 Aug 2005
  • Research & Ideas

The Hard Work of Failure Analysis

the folly of not adhering strictly to the company's core beliefs.2 Similarly, we have observed failed consulting relationships in our field research in which the consultants simply blamed the failure on the client, concluding that the... View Details
Keywords: by Amy Edmondson & Mark D. Cannon
  • 20 Jan 2015
  • First Look

First Look: January 20

diplomacy, are not innate talents but can be learned. It lists problems that research has shown often occur in the process of seeking or giving advice, including being overconfident about one's own perspective, failing to seek advice from... View Details
Keywords: Sean Silverthorne
  • Article

Governments as Owners: State-Owned Multinational Companies

By: Alvaro Cuervo-Cazurra, Andrew Inkpen, Aldo Musacchio and Kannan Ramaswamy
The globalization of state-owned multinational companies (SOMNCs) has become an important phenomenon in international business (IB), yet it has received scant attention in the literature. We explain how the analysis of SOMNCs can help advance the literature by... View Details
Keywords: Multinational Corporation; State-owned Enterprises; State Capitalism; FDI; Internationalization; Government And Business; National Oil Companies; State Ownership; Multinational Firms and Management; Business Subsidiaries; Acquisition; Pharmaceutical Industry; Pharmaceutical Industry; China; India; Europe
Related
  • 01 Jul 2008
  • First Look

First Look: July 1, 2008

the customer knowledge gained from conducting market research at the front end of NPD affects which of these opportunities the firm should pursue. Pitfalls in analyzing the customer data are described, along with guidelines on how to... View Details
Keywords: Martha Lagace
  • 16 Jun 2015
  • First Look

First Look: June 16, 2015

particularly in the vaccine space, had begun to attract the attention of much larger pharmaceutical companies. While there was much appeal to working with these companies, these relationships could also challenge Crucell's independence.... View Details
Keywords: Sean Silverthorne
  • 04 May 2010
  • First Look

First Look: May 4

Reexamination of Tunneling and Business Groups: New Data and New Methods Authors:Jordan I. Siegel and Prithwiraj Choudhury Abstract The last decade of corporate governance research has been focused in large part on identifying what leads... View Details
Keywords: Martha Lagace
  • 13 Jan 2009
  • First Look

First Look: January 13, 2009

and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70... View Details
Keywords: Martha Lagace
  • 25 Feb 2014
  • First Look

First Look: February 25

the weakening of democratic governance and the politics of decisions about industrial policy. Publisher's link: http://www.psupress.org/books/titles/978-0-271-05631-9.html August 2013 Research Policy Digital Dark Matter and the Economic... View Details
Keywords: Sean Silverthorne
  • 17 Mar 2009
  • First Look

First Look: March 17, 2009

Agreements in Bio-Pharmaceuticals Authors:Juan Alcácer, John Cantwell, and Michelle Gittelman Publication:In Location of Biopharmaceutical Activity, edited by Iain M. Cockburn and Matthew J. Slaughter. NBER, forthcoming. Abstract As the value chain of the View Details
Keywords: Martha Lagace
  • 15 Jan 2013
  • First Look

First Look: January 15

and Use of a New Accounting System Authors:Narayanan, V.G., Ranjani Krishnan, and Jamshed J. Mistry Publication:Journal of Management Accounting Research Abstract This study examines the attitudes, use, and acceptance of a new accounting... View Details
Keywords: Sean Silverthorne